| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/17/2000 | WO1999061613A3 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
| 02/17/2000 | CA2339638A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 02/16/2000 | EP0979831A2 Antibacterial peptides and antibacterial agents containing such peptides as an effective ingredient |
| 02/16/2000 | EP0979829A2 Cosmetic or dermatologic compositions containing oligopeptides for clearing age spots, e.g. for prevention of skin tanning, in particular when caused by UV-radiations |
| 02/16/2000 | EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979245A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof |
| 02/16/2000 | EP0979244A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
| 02/16/2000 | EP0979243A2 Activation of peptides |
| 02/16/2000 | EP0979241A1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta |
| 02/16/2000 | EP0979238A1 Method of alleviating neuropathic pain |
| 02/16/2000 | EP0979094A2 Agent for enhancing the heart force |
| 02/16/2000 | EP0561885B1 Subunit papillomavirus vaccine |
| 02/16/2000 | CN1244860A Cyclic imines as pesticides |
| 02/16/2000 | CN1244769A Antimicrobial proteins |
| 02/16/2000 | CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025471 Diazaspiro, azepino and azabicyclo therapeutic peptides |
| 02/15/2000 | US6025470 Provoke proliferation of cytolytic t cells |
| 02/15/2000 | US6025469 Murine UCP3 polypeptides |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025466 With antitumor activity |
| 02/15/2000 | US6025326 Compositions and methods for the prevention and treatment of oral mucositis |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/15/2000 | US6024955 Peptide with amino acid sequences |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | CA1340896C Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins |
| 02/10/2000 | WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy |
| 02/10/2000 | WO2000006604A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 02/10/2000 | WO2000006599A1 Inhibitors of hiv membrane fusion |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006186A1 Alpha-1 proteinase inhibitor binding peptides |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999062563A3 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors |
| 02/10/2000 | WO1999054728A3 Method of predicting receptor modulating activity |
| 02/10/2000 | DE19822823A1 Neue Peptidfragmente zur Reinigung von Proteinen New peptide fragments in protein purification |
| 02/10/2000 | CA2338022A1 Inhibitors of hiv membrane fusion |
| 02/09/2000 | EP0977774A1 Antipathogenic synthetic peptides and compositions comprising them |
| 02/09/2000 | EP0977579A1 Gastrin receptor-avid peptide conjugates |
| 02/09/2000 | CN1244126A Universal T-cell epitopes for anti-malarial vaccines |
| 02/08/2000 | US6022966 Conjugate comprises a dota chelate component, a biotin component and a linker component resistant to biotinidase cleavage |
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022857 Radiolabeled compounds for thrombus imaging |
| 02/08/2000 | US6022851 Cyclic polypeptides for treatment and prophylaxis of antibiotic-resistant bacterial infectious diseases by administration with an excipient |
| 02/08/2000 | US6022739 Systemin |
| 02/08/2000 | US6022696 Methods of identifying agonists or antagonists of angiotensin IV |
| 02/08/2000 | US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential |
| 02/08/2000 | US6022685 Methods and compositions for detecting anti-hepatitis E virus activity |
| 02/08/2000 | US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 02/08/2000 | US6022520 Administering a diagnostic amount of a radiolabeled reagent capable of inhibiting human platelet aggregation comprising radiolabel complexing moiety and a platelet glycoprotein iib/iiia-binding compound covalently linked to the moiety |
| 02/08/2000 | CA2093214C Isolated metallopolypeptide: compositions and synthetic methods |
| 02/03/2000 | WO2000005417A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | WO2000005363A1 Method for screening of modulators of calcineurin activity |
| 02/03/2000 | WO2000005254A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/03/2000 | WO2000005251A1 Aerothricin analogs, their preparation and use |
| 02/03/2000 | WO2000005250A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000004915A1 Compositions and methods for the treatment or prevention of pulmonary infections |
| 02/03/2000 | WO2000004914A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | CA2337688A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2335392A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | CA2335278A1 Method for screening of modulators of calcineurin activity |
| 02/03/2000 | CA2334947A1 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/02/2000 | EP0976823A1 Recombinant expression system and high throughput BioAssay for the therapeutic use of calcineurine-A- alpha, calcineurine-A-beta, calcineurine-A-gamma, calcineurine-B und Cu/Zn-superoxide dismutase respectively for the identification of pharmaceuticals |
| 02/02/2000 | EP0975963A1 Prostate specific antigen substrates |
| 02/02/2000 | EP0975792A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
| 02/02/2000 | EP0975747A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
| 02/02/2000 | EP0975743A1 Inhibitors for urokinase receptor |
| 02/02/2000 | EP0975661A1 The proliferation of cell-inhibiting peptide and its use |
| 02/02/2000 | EP0975374A1 Radiometal-binding peptide analogues |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/02/2000 | EP0584136B1 Determination of motifs of peptides on mhc molecules |
| 02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
| 02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
| 02/01/2000 | US6020461 Detection of gonorrhea is one area in which nucleic acid hybridization holds great potential as a diagnostic tool in clinical medicine. |
| 02/01/2000 | US6020460 Conformationally stabilized cell adhesion peptides |
| 02/01/2000 | US6020312 Synthetic antibiotics |
| 02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 01/27/2000 | WO2000004044A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/27/2000 | WO2000004043A1 Protease susceptibility ii |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999058564B1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 01/27/2000 | CA2337103A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/26/2000 | EP0974653A2 Human gastric cancer antigen gene and protein |
| 01/26/2000 | EP0973801A1 GnRH ANTAGONISTS |
| 01/26/2000 | EP0973800A1 Novel receptor |
| 01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/26/2000 | EP0973798A1 Inhibition of major groove dna binding proteins by modified polyamides |
| 01/26/2000 | EP0973797A1 Peptide compositions which induce immune tolerance and methods of use |
| 01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
| 01/26/2000 | EP0973539A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |